Literature DB >> 29971615

An efficient and facile synthesis of new tetracyclic fused pyrazolo[4,3-c][1,2,4]triazino[4,5-a]quinolin-4(5H)-ones.

Mohsen A-M Gomaa1, Huda A Ali2.   

Abstract

Reaction of amidrazones 1a-1i with (1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)propanedinitrile (2) in ethyl acetate solution in one-step reaction led to the formation of unprecedented pyrazolo[4,3-c][1,2,4]triazino[4,5-a]quinolin-4(5H)-ones 3a-3g along with pyrazolo[4,3-c][1,2,4]triazino[4,5-a]quinolin-12b-oles 3h-3m in moderate to excellent yields. These novel heterocycles were formed via a Michael addition reaction followed by intramolecular cyclization via a dearomatization process.

Entities:  

Keywords:  (1,5-dihydro-3-methyl-5-oxo-1-phenyl-4H-pyrazol-4-ylidene)propanedinitrile; Amidrazone; Dearomatization; Pyrazolo[4,3-c][1,2,4]triazino[4,5-a]quinolone

Mesh:

Substances:

Year:  2018        PMID: 29971615     DOI: 10.1007/s11030-018-9849-9

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  17 in total

1.  Synthesis of heterobicyclic nitrogen systems bearing the 1,2,4-triazine moiety as anti-HIV and anticancer drugs: Part I.

Authors:  R M Abdel-Rahman; J M Morsy; F Hanafy; H A Amene
Journal:  Pharmazie       Date:  1999-05       Impact factor: 1.267

2.  Synthesis of 1,2,4-triazine derivatives as potential anti-anxiety and anti-inflammatory agents.

Authors:  Pooja Mullick; Suroor A Khan; Tauseef Begum; Surajpal Verma; Darpan Kaushik; Ozair Alam
Journal:  Acta Pol Pharm       Date:  2009 Jul-Aug       Impact factor: 0.330

3.  Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development.

Authors:  Mark D Wittman; Joan M Carboni; Zheng Yang; Francis Y Lee; Melissa Antman; Ricardo Attar; Praveen Balimane; Chiehying Chang; Cliff Chen; Lorell Discenza; David Frennesson; Marco M Gottardis; Ann Greer; Warren Hurlburt; Walter Johnson; David R Langley; Aixin Li; Jianqing Li; Peiying Liu; Harold Mastalerz; Arvind Mathur; Krista Menard; Karishma Patel; John Sack; Xiaopeng Sang; Mark Saulnier; Daniel Smith; Kevin Stefanski; George Trainor; Upender Velaparthi; Guifen Zhang; Kurt Zimmermann; Dolatrai M Vyas
Journal:  J Med Chem       Date:  2009-12-10       Impact factor: 7.446

4.  Catalytic asymmetric formal [3+3] cycloaddition of an azomethine ylide with 3-indolylmethanol: enantioselective construction of a six-membered piperidine framework.

Authors:  Feng Shi; Ren-Yi Zhu; Wei Dai; Cong-Shuai Wang; Shu-Jiang Tu
Journal:  Chemistry       Date:  2014-02-02       Impact factor: 5.236

5.  Enantioselective Construction of Spiro[indoline-3,2'-pyrrole] Framework via Catalytic Asymmetric 1,3-Dipolar Cycloadditions Using Allenes as Equivalents of Alkynes.

Authors:  Cong-Shuai Wang; Ren-Yi Zhu; Jian Zheng; Feng Shi; Shu-Jiang Tu
Journal:  J Org Chem       Date:  2014-12-16       Impact factor: 4.354

6.  Application of 3-Methyl-2-vinylindoles in Catalytic Asymmetric Povarov Reaction: Diastereo- and Enantioselective Synthesis of Indole-Derived Tetrahydroquinolines.

Authors:  Wei Dai; Xiao-Li Jiang; Ji-Yu Tao; Feng Shi
Journal:  J Org Chem       Date:  2015-12-21       Impact factor: 4.354

7.  Synthesis of some new thioethers of 1,2,4-triazine-3-hydrazones and assays for their anticancer and anti human immune virus activities.

Authors:  R M Abdel-Rahman; M Seada; M Fawzy; I el-Baz
Journal:  Farmaco       Date:  1993-03

8.  Synthesis and anti human immune virus activity of some new fluorine containing substituted -3-thioxo-1,2,4-triazin-5-ones.

Authors:  R M Abdel-Rahman
Journal:  Farmaco       Date:  1991-02

9.  Synthesis of some new 1,6-dihydro-3-substituted 6-spiro-(9'-fluorene)-1,2,4-triazin-5-(4H)-ones as potential anti HIV and anticancer drugs.

Authors:  R M Abdel-Rahman; M Seada; M Fawzy; I el-Baz
Journal:  Pharmazie       Date:  1994-10       Impact factor: 1.267

10.  Synthesis of some new fluorine bearing trisubstituted 3-thioxo-1,2,4-triazin-5-ones as potential anticancer agents.

Authors:  R M Abdel-Rahman
Journal:  Farmaco       Date:  1992-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.